RSNA 2014 

Abstract Archives of the RSNA, 2014


SSM04-02

Acute Response of Right Ventricular Morphology and Function to Iloprost Inhalations in Patients with Pulmonary Arterial Hypertension: Noninvasive Evaluation with Cardiac Magnetic Resonance Imaging

Scientific Papers

Presented on December 3, 2014
Presented as part of SSM04: Cardiac (Pulmonary Artery Disease)

 Trainee Research Prize - Medical Student

Participants

Qingqing Lu, Abstract Co-Author: Nothing to Disclose
Yan Han, Abstract Co-Author: Nothing to Disclose
Dong Li MD, Abstract Co-Author: Nothing to Disclose
Zhang Zhang, Presenter: Nothing to Disclose
Tielian Yu, Abstract Co-Author: Nothing to Disclose

PURPOSE

Cardiac magnetic resonance (CMR) has been an accurate and reproducible tool to assessment of right ventricular (RV) morphology and function, which are important factors in the outcome of patients with pulmonary arterial hypertension (PAH). Iloprost inhalation has shown an effective therapy for severe primary pulmonary hypertension. This study aims to investigate acute RV response to inhalation of aerosolized iloprost in patients with PAH using CMR.

METHOD AND MATERIALS

Between March 2012 and March 2014, 53 patients with PAH(39.5 years ±12; 5 male) underwent CMR before and after inhalation of iloprost with a single dose of 20μg over 15-20 minutes. The CMR images were analyzed to obtain the RV morphology and function parameters before and after iloprost inhalation, including end-diastolic volume(EDV), end-systolic volume(ESV), stroke volume(SV), ejection fraction(EF), cardiac output(CO), end-diastolic area(EDA) and end-systolic area(ESA). Percentage of RV area change was also calculated [%RVAC=(EDA-ESA)/EDA]. Paired Samples t Test was used to compare the differences of RV morphology and function parameters.

RESULTS

After iloprost inhalation, all patients showed significant decrease in EDV[(207.8±88.4)mlvs. (201.0±88.8)ml, P<0.001)] and ESV[(142.5±77.9) ml vs. (129.0±74.8)ml,P<0.001]. Whereas, there were significant increase in SV[(65.3±22.5)mlvs.(72.1±24.2)ml,P<0.001], EF[(34.8±12.5)%vs. (39.4±12.8)%,P<0.001], CO[(5.3±1.9)L/minvs.(5.5±2.1)L/min,P=0.01], and %RVAC[(19.4±13.0) vs. (23.8±11.2), P<0.001] .

CONCLUSION

Inhalation of iloprost can improve RV morphology and function in patients with PAH, and evaluation of the acute response with CMR is feasibility.

CLINICAL RELEVANCE/APPLICATION

CMR has value in providing direct changes in RV morphology and function to therapy in patients with PAH.

Cite This Abstract

Lu, Q, Han, Y, Li, D, Zhang, Z, Yu, T, Acute Response of Right Ventricular Morphology and Function to Iloprost Inhalations in Patients with Pulmonary Arterial Hypertension: Noninvasive Evaluation with Cardiac Magnetic Resonance Imaging.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14013562.html